Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Circulating invariant natural killer T-cell numbers predict outcome in head and neck squamous cell carcinoma: updated analysis with 10-year follow-up.

Schneiders FL, de Bruin RC, van den Eertwegh AJ, Scheper RJ, Leemans CR, Brakenhoff RH, Langendijk JA, Verheul HM, de Gruijl TD, Molling JW, van der Vliet HJ.

J Clin Oncol. 2012 Feb 10;30(5):567-70. doi: 10.1200/JCO.2011.38.8819. Epub 2012 Jan 17. No abstract available.

PMID:
22253469
2.

Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma.

Molling JW, Langius JA, Langendijk JA, Leemans CR, Bontkes HJ, van der Vliet HJ, von Blomberg BM, Scheper RJ, van den Eertwegh AJ.

J Clin Oncol. 2007 Mar 1;25(7):862-8.

PMID:
17327607
3.

T-cell subsets and natural killer cell function with squamous cell carcinoma of the head and neck.

Strome M, Clark JR, Fried MP, Rodliff S, Blazar BA.

Arch Otolaryngol Head Neck Surg. 1987 Oct;113(10):1090-3.

PMID:
3497652
4.

Production of lymphokine-activated lymphocytes. Lysis of human head and neck squamous cell carcinoma cell lines.

Alessi DM, Hutcherson RW, Mickel RA.

Arch Otolaryngol Head Neck Surg. 1989 Jun;115(6):725-30.

PMID:
2785809
5.

Total lymphocyte and T lymphocyte subpopulation levels in head and neck squamous cell carcinomas.

Soysal V, Yigitbasi OG, Alper M, Patiroglu T, Güney E.

J Exp Clin Cancer Res. 1998 Jun;17(2):207-12.

PMID:
9700582
6.

Identification of subsets of lymphocytes infiltrating head and neck tumor tissue: a preliminary report.

Rabin BS, Johnson J, Claassen D.

Laryngoscope. 1984 May;94(5 Pt 1):688-90.

PMID:
6232437
7.

Association of CD47 with natural killer cell-mediated cytotoxicity of head-and-neck squamous cell carcinoma lines.

Kim MJ, Lee JC, Lee JJ, Kim S, Lee SG, Park SW, Sung MW, Heo DS.

Tumour Biol. 2008;29(1):28-34. doi: 10.1159/000132568. Epub 2008 May 23.

PMID:
18497546
8.
9.

Intratumoral recombinant human interleukin-12 administration in head and neck squamous cell carcinoma patients modifies locoregional lymph node architecture and induces natural killer cell infiltration in the primary tumor.

van Herpen CM, van der Laak JA, de Vries IJ, van Krieken JH, de Wilde PC, Balvers MG, Adema GJ, De Mulder PH.

Clin Cancer Res. 2005 Mar 1;11(5):1899-909.

10.

Assessment of immunocompetent cells in patients with head and neck squamous cell carcinoma.

Dawson DE, Everts EC, Vetto RM, Burger DR.

Ann Otol Rhinol Laryngol. 1985 Jul-Aug;94(4 Pt 1):342-5.

PMID:
3875306
11.

Toll-like receptor modulation in head and neck cancer.

Pries R, Wulff S, Wollenberg B.

Crit Rev Immunol. 2008;28(3):201-13. Review.

PMID:
19024345
12.

Interleukins 2 and 12 activate natural killer cytolytic responses of peripheral blood mononuclear cells from patients with head and neck squamous cell carcinoma.

Rashleigh SP, Kusher DI, Endicott JN, Rossi AR, Djeu JY.

Arch Otolaryngol Head Neck Surg. 1996 May;122(5):541-7.

PMID:
8615973
13.

Perilymphatic injections of recombinant interleukin-2 (rIL-2) partially correct the immunologic defects in patients with advanced head and neck squamous cell carcinoma.

Melioli G, Margarino G, Scala M, Mereu P, Bertoglio S, Schenone G, Barbaresi M, Machí AM, Santi L, Badellino F, et al.

Laryngoscope. 1992 May;102(5):572-8.

PMID:
1533435
14.

Immune restoration with interleukin-2 in patients with squamous cell carcinoma of the head and neck.

Wanebo HJ, Jones T, Pace R, Cantrell R, Levine P.

Am J Surg. 1989 Oct;158(4):356-60.

PMID:
2802041
15.

[Immunohistochemical study of cancer tissues. 1. Special reference to Leu-11b positive lymphocytes (NK cells)].

Ogawa Y, Maeda T, Inomata T, Yoshida S, Seguchi H, Kishimoto S, Saito H, Hirota S, Osaki T.

Nihon Gan Chiryo Gakkai Shi. 1988 Jun 20;23(6):1236-42. Japanese. No abstract available.

PMID:
2976419
16.

Differential sensitivity of head and neck cancers to non-major histocompatibility-restricted killer cell activity.

Schantz SP, Racz T, Ordonez NG, Terry N, Taylor DL, Bugis S, Sacks PG.

J Surg Res. 1990 Feb;48(2):154-64.

PMID:
2106056
17.
18.

Production by human squamous cell carcinoma of a factor inducing activation and proliferation of immune cells.

Hirabayashi H, Yasumura S, Lin WC, Amoscato A, Johnson JT, Herberman RB, Whiteside TL.

Arch Otolaryngol Head Neck Surg. 1995 Mar;121(3):285-92.

PMID:
7873144
19.

Neck node immunoreactivity in head and neck carcinoma.

Mandell-Brown M, Johnson JT, Rabin BS, Hamill E, Wagner RL.

Otolaryngol Head Neck Surg. 1986 Nov;95(4):500-6.

PMID:
2952933
20.

Supplemental Content

Support Center